43 completed, 10 recruiting, 9 unknown, 6 terminated. 36 Not applicable, 16 Phase 1, 16 Phase 2, 7 Phase 3, 2 Early Phase 1.
Follow Citrulline: new trials by email Literature Review of Citrulline trials Research Report on Citrulline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Pre-Run Nutritional Supplements During a Fixed-Pace 5 km Treadmill Run Caffeine, L-Citrulline, Exogenous Ketone (Beta-Hydroxybutyrate) - Exercise Physiology, Nutritional Supplementation | Not applicable | Recruiting | St. Louis University | 20 | 2026-10-01 | 2026-10-02 |
| L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction L-Citrulline, Tadalafil, L-Citrulline Placebo - Erectile Dysfunction | Phase 4 | Recruiting | Beni-Suef University | 133 | 2026-06-08 | 2026-06-12 |
| L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones L-Citrulline, Tamsulosin - Distal Ureteral Stone, Urolithiasis | Phase 2 | Recruiting | Beni-Suef University | 120 | 2026-05-06 | 2026-06-01 |
| Effect of a Daily Supplement on Plasma PAI-1 Levels Supplement with ginger extract, L-citrulline, Paullinia cupana, and muira puama - Aging, Endothelial Dysfunction | Phase 1 / Phase 2 | Active not recruiting | University of California, Los Angeles | 35 | 2026-02-24 | 2026-06-25 |
| L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) L-citrulline, Placebo - Infectious Disease, Infections | Not applicable | Recruiting | Barcelona Institute for Global Health | 2200 | 2025-12-08 | 2026-02-23 |
| A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis L-citrulline, Placebo - Sickle Cell Disease | Phase 3 | Not yet recruiting | Asklepion Pharmaceuticals, LLC | 120 | 2025-07-25 | 2025-05-29 |
| Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease L-citrulline, Placebo - Sickle Cell Disease, Vaso-occlusive Pain Episode | Phase 2 | Recruiting | Suvankar Majumdar | 99 | 2024-12-22 | 2026-04-13 |
| Nitrate Formulations and Exercise Performance Nitrate - Nitrate, Nitrate/Citrulline | Not applicable | Completed | University of Greenwich | 15 | 2024-08-01 | 2025-03-27 |
| Oral Citrulline Supplementation in COPD Patients With Malnutrition L-citrulline - Chronic Obstructive Pulmonary Disease Severe, Malnutrition | Phase 3 | Unknown | University Hospital, Grenoble | 60 | 2024-01-25 | 2024-01-19 |
| L-Citrulline and Endothelial Function L-Citrulline, capsule - Aging | Phase 1 | Completed | University of Oklahoma | 20 | 2024-01-03 | 2026-03-12 |
| L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) L-citrulline - Pregnancy, Malaria | Not applicable | Recruiting | Liverpool School of Tropical Medicine | 2960 | 2023-12-29 | 2025-06-27 |
| Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC L-Citrulline - BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension | Not applicable | Recruiting | The Hospital for Sick Children | 36 | 2023-11-01 | 2026-05-04 |
| 2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension L-Citrulline, Placebo - Menopause, Hypertension | Not applicable | Completed | Texas Tech University | 19 | 2023-07-20 | 2025-05-15 |
| The Effect of 4 Weeks of L-Citrulline Supplementation on Macro- and Microvascular Function in Type 2 Diabetes L-citrulline, Placebo - Type 2 Diabetes | Not applicable | Completed | Texas Tech University | 36 | 2023-05-01 | 2025-05-15 |
| Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD) L-citrulline, Carboxymethyl cellulose, High Intensity Intervals Training - Metabolic Dysfunction-Associated Fatty Liver Disease, Obesity, Adolescent | Not applicable | Completed | Universidad de Guanajuato | 43 | 2023-03-14 | 2024-12-20 |
| Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation L-citrulline, Placebo - Post Deployment Related Asthma, Asthma | Phase 2 | Recruiting | University of Colorado, Denver | 75 | 2023-03-08 | 2023-04-06 |
| The Effect of Short-term L-citrulline Supplementation on Blood Pressure and Arterial Stiffness L-Citrulline, Placebo - Blood Pressure | Not applicable | Completed | European University Cyprus | 12 | 2023-01-01 | 2023-08-03 |
| A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects L-citrulline, Plasmalyte A - Ventricular Septal Defect, Atrioventricular Septal Defect | Phase 3 | Terminated | Asklepion Pharmaceuticals, LLC | 64 | 2022-06-29 | 2024-09-19 |
| Effects of L-Citrulline or Citrulline-malate on Neuromuscular Performance in Resistance-trained Adults L-citrulline, Citrulline-malate, Placebo - Neuromuscular Performance | Not applicable | Completed | Universidad de Granada | 50 | 2022-02-15 | 2022-11-04 |
| Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes L-ctirulline, Matching Placebo - Asthma, Obesity | Phase 2 | Recruiting | University of Colorado, Denver | 60 | 2021-10-01 | 2025-06-10 |
Showing 20 of 71. Sign in to see all of them.
Hypertension (6) · Obesity (6) · Anemia, Sickle Cell (5) · Asthma (4) · Diabetes Mellitus, Type 2 (3) · Hypertension, Pulmonary (3) · Acute Lung Injury (2) · Bronchopulmonary Dysplasia (2) · Heart Defects, Congenital (2) · Malnutrition (2) · Peripheral Arterial Disease (2) · Pre-Eclampsia (2) · Premature Birth (2) · Protein-Energy Malnutrition (2) · Sepsis (2)
Asklepion Pharmaceuticals, LLC (6) · Texas Tech University (6) · Florida State University (3) · Nantes University Hospital (3) · University Hospital, Grenoble (3) · University of Colorado, Denver (3) · University of Pittsburgh (3) · Vanderbilt University (3) · Angiogenix (2) · Assistance Publique - Hôpitaux de Paris (2) · Baylor College of Medicine (2) · Beni-Suef University (2) · Rennes University Hospital (2) · Société des Produits Nestlé (SPN) (2) · Suvankar Majumdar (2)
United States (38) · France (9) · Canada (2) · Egypt (2) · Germany (2) · Mexico (2) · Netherlands (2) · Spain (2) · Austria (1) · Brazil (1) · Cyprus (1) · Ethiopia (1) · Iran (1) · Israel (1) · Jordan (1)
Arturo Figueroa (4) · Fernando Holguin, MD, MPH (3) · Gurdyal Kalsi, MD, MFPM (3) · Suvankar Majumdar, MD (2) · Abbie Smith-Ryan, PhD (1) · Alan Arturo Rodriguez-Carrillo, Bachelor (1) · Andriy Yabluchanskiy, MD, PhD (1) · Arturo Figueroa, M.D. Ph.D (1) · Arturo Figueroa, Ph.D, MD (1) · Ayman W El-Hattab, MD (1) · Brian W. Christman, MD (1) · Candice Fike, MD (1) · Carl A Hubel, PhD (1) · Christian Aussel, PHD (1) · Christopher Mastropietro, MD, FCCM (1)
PMID 17662768, PMID 10793157, PMID 16082501, PMID 19056593, PMID 19105791, PMID 20084502, PMID 20386132, PMID 20713972, PMID 21733603, PMID 22666356, PMID 23327349, PMID 23509945, PMID 23612995, PMID 23782971, PMID 25674699, PMID 25904650, PMID 26023227, PMID 26516419, PMID 26537365, PMID 27600147, PMID 29057836, PMID 29380952, PMID 30130468, PMID 30642738, PMID 31350908, PMID 31714895, PMID 31977835, PMID 32125249, PMID 32403259, PMID 33064413, PMID 33187518, PMID 34200431, PMID 36316628, PMID 37125500, PMID 37333204, PMID 37784110, PMID 37907796, PMID 39385595, PMID 39638148, PMID 39662304, PMID 3968652, PMID 39940261, PMID 42595807, PMID 42753870, PMID 7994830
R01HL073317 (2), 2016 (1), I01CX002152 (1), P01HD030367 (1), R01HL146542 (1), R61HL167806 (1), U54NS078059 (1)